Contrast Media & Molecular Imaging

Theranostic Probes for Cancer Imaging


Publishing date
18 Aug 2017
Status
Published
Submission deadline
31 Mar 2017

Lead Editor

1Xidian University, Xi’an, China

2Emory University, Atlanta, USA

3Soochow University, Suzhou, China


Theranostic Probes for Cancer Imaging

Description

Theranostics refers to the integration of specialized diagnosis and therapy, which makes it possible to arrive at a comprehensive diagnostic and an individual treatment regimen by embracing various techniques. With the emerging of material chemistry and nanomedicine, theranostic probes have received extensive attention as a robust tool for monitoring diagnostic or therapeutic efficacy in cancer research. The novel theranostic probes hold great potential in the assessment of cancer at its earliest stages, determining its precise location within the body, monitoring the in vivo drug delivery to target tumor site, and evaluating the therapeutic efficacy following treatment. Such theranostic probes would definitely change the way we diagnose, image, and treat cancer.

This special issue would focus on the various probes that are extensively developed for cancer diagnostics and therapeutics. This issue accepts original research articles as well as review articles that will show a diversity of new developments in these areas. It will establish a multidisciplinary forum of discussion on diverse theranostic probes capable of simultaneously imaging and treating cancer.

Potential topics include but are not limited to the following:

  • Magnetic nanoparticle-based theranostic probes
  • Radionuclide nanoparticle-based theranostic probes
  • Optical imaging probes
  • Ultrasound imaging probes
  • Raman imaging probes
  • Photoacoustic imaging probes
  • Reporter gene-based theranostic probes

Articles

  • Special Issue
  • - Volume 2017
  • - Article ID 1863803
  • - Editorial

Theranostic Probes for Cancer Imaging

Fu Wang | Lei Zhu | ... | Dongkyoo Park
  • Special Issue
  • - Volume 2017
  • - Article ID 3625729
  • - Research Article

Gd3+-Asparagine-Anionic Linear Globular Dendrimer Second-Generation G2 Complexes: Novel Nanobiohybrid Theranostics

Nasim Hashempour Alamdari | Mahmood Alaei-Beirami | ... | Mehdi Shafiee Ardestani
  • Special Issue
  • - Volume 2017
  • - Article ID 4972701
  • - Research Article

Preclinical Evaluation and Monitoring of the Therapeutic Response of a Dual Targeted Hyaluronic Acid Nanodrug

Minglong Chen | Wenqi Zhang | ... | Shi Gao
  • Special Issue
  • - Volume 2017
  • - Article ID 1026270
  • - Review Article

Molecular Imaging of Cancer with Nanoparticle-Based Theranostic Probes

Ying-Yu Ma | Ke-Tao Jin | ... | Xiao-Zhou Mou
  • Special Issue
  • - Volume 2017
  • - Article ID 8160134
  • - Research Article

Labelling of Y- and Lu-DOTA-Bioconjugates for Targeted Radionuclide Therapy: A Comparison among Manual, Semiautomated, and Fully Automated Synthesis

Michele Iori | Pier C. Capponi | ... | Mattia Asti
  • Special Issue
  • - Volume 2017
  • - Article ID 1686525
  • - Research Article

MicroPET/CT Imaging of AXL Downregulation by HSP90 Inhibition in Triple-Negative Breast Cancer

Wanqin Wang | Jun Zhao | ... | Chun Li
  • Special Issue
  • - Volume 2017
  • - Article ID 7064120
  • - Review Article

Clinical Applications of Contrast-Enhanced Perfusion MRI Techniques in Gliomas: Recent Advances and Current Challenges

Junfeng Zhang | Heng Liu | ... | Weiguo Zhang
Contrast Media & Molecular Imaging
 Journal metrics
Acceptance rate45%
Submission to final decision69 days
Acceptance to publication56 days
CiteScore2.440
Impact Factor1.984
 Submit
 Author guidelines  Editorial board  Databases and indexing
 Sign up for content alertsSign up

Publishing Collaboration

More info
Wiley-Hindawi